Carvedilol and Pulmonary function test decreased - a phase IV clinical study of FDA data
Summary:
Pulmonary function test decreased is reported as a side effect among people who take Carvedilol (carvedilol), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Furosemide, and have Chronic obstructive pulmonary disease.
The phase IV clinical study analyzes which people have Pulmonary function test decreased when taking Carvedilol. It is created by eHealthMe based on reports of 110,224 people who have side effects when taking Carvedilol from the FDA, and is updated regularly.
What is Carvedilol?
Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.
What is Pulmonary function test decreased?
Pulmonary function test decreased is found to be associated with 469 drugs and 497 conditions by eHealthMe. Check the latest studies of Pulmonary function test decreased.
110,224 people reported to have side effects when taking Carvedilol.
Among them, 36 people (0.03%) have Pulmonary function test decreased.
Among these 36 people:
How long have people been on Carvedilol when they have Pulmonary function test decreased? *
- < 1 month: 0.0 %
- 1 - 6 months: 44.44 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 55.56 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Pulmonary function test decreased when taking Carvedilol? *
- female: 26.47 %
- male: 73.53 %
What is the age of people who have Pulmonary function test decreased when taking Carvedilol? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 4 %
- 50-59: 0.0 %
- 60+: 96 %
What are other drugs people take besides Carvedilol? *
- Spironolactone: 7 people, 19.44%
- Hydrochlorothiazide: 7 people, 19.44%
- Furosemide: 7 people, 19.44%
- Lyrica: 6 people, 16.67%
- Metformin: 6 people, 16.67%
- Clopidogrel: 6 people, 16.67%
- Lisinopril: 6 people, 16.67%
- Omniscan: 5 people, 13.89%
- Prohance: 5 people, 13.89%
- Protonix: 5 people, 13.89%
What are other side effects people have besides Pulmonary function test decreased? *
- Dyspnea (difficult or laboured breathing): 11 people, 30.56%
- Fatigue (feeling of tiredness): 10 people, 27.78%
- Weakness: 10 people, 27.78%
- Nausea (feeling of having an urge to vomit): 8 people, 22.22%
- Cough: 8 people, 22.22%
- Headache (pain in head): 7 people, 19.44%
- Skin Ulcer: 7 people, 19.44%
- Pain: 7 people, 19.44%
- Asthma: 6 people, 16.67%
- Skin Disorder (skin disease): 6 people, 16.67%
What are the existing conditions these people have? *
- High Blood Cholesterol: 7 people, 19.44%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 19.44%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 16.67%
- Cardiac Failure Congestive: 5 people, 13.89%
- Diabetes: 4 people, 11.11%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 11.11%
- Cardiac Disorder: 3 people, 8.33%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 8.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.56%
- Amyotrophic Lateral Sclerosis (nervous system disease that attacks nerve cells called neurons in your brain and spinal cord): 2 people, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Carvedilol and have Pulmonary function test decreased?
- Check whether Pulmonary function test decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Carvedilol:
- Carvedilol (112,649 reports)
Pulmonary function test decreased treatments and more:
- Pulmonary function test decreased (5,517 reports)
How severe was Pulmonary function test decreased and when was it recovered:
Expand to all the drugs that have ingredients of carvedilol:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Carvedilol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pulmonary function test decreased:
- Pulmonary function test decreased (469 drugs)
Browse all the conditions that are associated with Pulmonary function test decreased:
- Pulmonary function test decreased (497 conditions)
Related publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on carvedilol (the active ingredients of Carvedilol) and Carvedilol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Haloperidol cause Electrocardiogram St Segment Elevation? - 9 seconds ago
- Could Diuril cause Stress And Anxiety? - 11 seconds ago
- Rashes and Hearing Loss - 19 seconds ago
- Could Midazolam cause Infection? - 27 seconds ago
- Drug interactions of Effexor Xr and Zyrtec-D 12 Hour - 30 seconds ago
- Accuretic vs. Inspra, side effect and effectiveness comparison - 32 seconds ago
- Diovan vs. Welchol, side effect and effectiveness comparison - 44 seconds ago
- Could Kesimpta cause Pharyngitis? - 48 seconds ago
- Drug interactions of Cholestyramine and Baclofen - 50 seconds ago
- Gastric Cancer and Chronic Obstructive Pulmonary Disease - 56 seconds ago